Synonyms: BMS 908662 | BMS908662 | XL281
Compound class:
Synthetic organic
Comment: BMS908662 is an orally active, small molecule B-RAF inhibitor with potential antineoplastic activity.
|
|
No information available. |
Summary of Clinical Use |
A Phase 1/II clinical trial has been completed. This trial (NCT01086267) assessed BMS908662 alone or in combination with the approved anti-EGFR monoclonal antibody cetuximab, in patients with K-RAS or B-RAF mutation positive advanced or metastatic colorectal cancer. |